Neurobehavioral, neuroendocrine and neurochemical effects of zinc supplementation in rats.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D004723:Endorphins / Q000378:metabolism; D066298:In Vitro Techniques; D007276:Injections, Intraventricular; D009270:Naloxone / Q000378:metabolism; D010146:Pain / Q000503:physiopathology; D010902:Pituitary Gland / Q000378:metabolism; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects*; D011957:Receptors, Opioid / Q000187:drug effects*; D012640:Seizures / Q000139:chemically induced; D015032:Zinc / Q000378:metabolism / Q000494:pharmacology*; D001615:beta-Endorphin; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D004723:Endorphins; D011963:Receptors, GABA-A; D011957:Receptors, Opioid; D009270:Naloxone; D005680:gamma-Aminobutyric Acid; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone; D001418:Baclofen; D015032:Zinc; D003975:Diazepam